| Patient | Michelangelo Buonarroti |
|---|---|
| Date of birth | 1941-03-06 |
| Identifiers | MRN HR-RE002-SYN; SSN (made up) 000-02-7781 |
| Document date | 2026-04-13 |
| Author | Serena Castellano, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-week hand osteoarthritis review after stopping ibuprofen; rheumatology consultation today. [S]
Mr. Buonarroti returns four weeks after stopping over-the-counter ibuprofen 1200 mg a day and starting diclofenac gel four times daily, acetaminophen as needed, and a left thumb-base splint. He uses the gel faithfully and takes acetaminophen 1 g about twice a day. His hand pain is somewhat better, about 5 of 10, but gripping a chisel for more than an hour still brings on a deep ache at the base of the left thumb, and morning stiffness lasts about 15 minutes. He wears the splint for carving and at night. He has not yet started hand therapy because of a waiting list. He has had no gout flare, urinary symptoms, rash, or stomach upset. He saw the rheumatologist this morning and had the thumb-base injection. [S]
| Element | Detail |
|---|---|
| Pain | About 5 of 10, worst at the left thumb base after an hour of carving |
| Stiffness | About 15 minutes in the morning |
| Treatment use | Diclofenac gel four times daily; acetaminophen 1 g about twice a day; splint for carving and at night |
| Ibuprofen | None since the last visit |
| Hand therapy | Not started; on a waiting list |
| Gout and stones | No flare; no urinary symptoms |
| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Positive | Left thumb-base ache with use; brief morning stiffness; no joint swelling elsewhere; no foot pain |
| Integumentary | Negative | No rash where the gel is applied |
| Gastrointestinal | Negative | No indigestion or dark stools |
| Genitourinary | Negative | No flank pain or blood in the urine |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ibuprofen 200 mg oral tablet (over the counter), two tablets by mouth three times daily | Two tablets by mouth three times daily | Oral route | 2025-12-01 to 2026-03-16 | stopped | S |
| Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth daily | Two tablets by mouth daily | Oral route | 2018-06-04 | active | S |
| Diclofenac sodium 1% topical gel, 2 g to the painful hand joints four times daily, no more than 8 g a day to either hand | Apply 2 g to the affected hand joints four times daily | Topical route | 2026-03-16 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times daily as needed for hand pain, no more than 3 g a day | Two tablets up to three times daily as needed; maximum 6 tablets a day | Oral route | 2026-03-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-13 | Body height | 168 | cm | S |
| 2026-04-13 | Body weight | 61.8 | kg | S |
| 2026-04-13 | Body mass index (BMI) [Ratio] | 21.9 | kg/m2 | S |
| 2026-04-13 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-04-13 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-04-13 | Heart rate | 70 | /min | S |
| 2026-04-13 | Respiratory rate | 16 | /min | S |
| 2026-04-13 | Body temperature | 36.7 | Cel | S |
| 2026-04-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-13 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-13 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-13 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 | mmol/L | 22-29 mmol/L | Normal | S |
| 2026-04-13 | Urea nitrogen [Mass/volume] in Serum or Plasma | 20 | mg/dL | 8-23 mg/dL | Normal | S |
| 2026-04-13 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-04-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 72 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-13 | Glucose [Mass/volume] in Serum or Plasma | 90 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-04-13 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S | ||
| 2026-04-13 | PROMIS upper extremity version 2.0 T-score | 37 | {T-score} | S | ||
| 2026-04-13 | Grip strength Hand - left Dynamometer | 15 | kg | S | ||
| 2026-04-13 | Grip strength Hand - right Dynamometer | 22 | kg | S |
Vital signs recorded on 2026-04-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well, wiry, and impatient to get back to work |
| Left hand | Squaring and tenderness at the first carpometacarpal joint with a positive grind test; bony enlargement of the thumb metacarpophalangeal and interphalangeal and the index metacarpophalangeal and proximal interphalangeal joints; no warmth or soft swelling; thumb abduction reduced |
| Right hand | Heberden nodes of the index and middle fingers; no synovitis |
| Feet | No tophi, warmth, or swelling |
| Cardiovascular | Regular rhythm |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Primary osteoarthritis of the left hand, worst at the thumb base (first carpometacarpal joint, Eaton stage III), with thumb metacarpophalangeal and interphalangeal and index metacarpophalangeal and proximal interphalangeal involvement; non-erosive | active | confirmed | M19.042 | S — Synthetic modern diagnosis confirmed by examination and radiographs. The joint pattern echoes the retrospective portrait-based interpretation (R, possible), which remains a hypothesis about the historical person; his documented difficulty writing is D. |
| Primary osteoarthritis of the right hand, mild, with Heberden nodes of the index and middle fingers | active | confirmed | M19.041 | S — Synthetic modern diagnosis; the portraits studied show only the left hand. |
| Chronic gout without tophi, in remission on allopurinol with serum urate at target | active | confirmed | M1A.9XX0 | S — Synthetic modern diagnosis, crystal-proven years ago in the synthetic history. Gout in the historical person is a retrospective reading of period language (R, possible). |
| History of urinary stones, passed spontaneously years ago; stone-free on fluids and allopurinol | active | confirmed | Z87.442 | S — Synthetic modern entry linked to the urinary calculus documented in his own letters (D); the composition of his historical stones is not known. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Hand pain, 0 to 10 numeric rating | Each clinical encounter; after each therapeutic trial | Completed today | 5 of 10, down from 7 |
| Survey | Validated function measure (PROMIS upper extremity T-score; AUSCAN and FIHOA have no LOINC code) | Each clinical encounter | Completed today | T-score 37 (population mean 50; higher is better) |
| Examination | Grip strength by dynamometer | Each clinical encounter in this plan | Completed today | Left 15 kg, right 22 kg |
| Examination | Joint examination: range of motion, swelling, alignment, crepitus | Each clinical encounter | Completed today | No synovitis; thumb-base grind positive; reduced thumb abduction |
| Laboratory | Creatinine, potassium, and blood pressure after stopping a chronic oral NSAID | Periodically on chronic oral NSAIDs; recheck after stopping when kidney function fell | Completed today | Creatinine 1.02 mg/dL (eGFR 72), down from 1.21 (eGFR 59) on ibuprofen; potassium 4.5 mmol/L; blood pressure 134/78, down from 148/82 |
| Medication safety | Oral NSAID avoidance and topical NSAID use | Each clinical encounter | Completed today | No ibuprofen; diclofenac gel about 8 g a day, within the limit for the hands |
| Medication safety | Acetaminophen dose | Each clinical encounter while used regularly | Completed today | About 2 g a day, under the 3 g limit |
| Laboratory | ALT on regular acetaminophen | Periodically, especially near 3 g a day | Up to date | ALT 18 U/L last month; recheck in about six months |
| Referral | Occupational hand therapy | At diagnosis, as part of first-line care | Deferred | Requested at intake and not started four weeks later because of a waiting list, a delay in the protocol's first-line care. No harm so far: pain and function are improving. Corrective action: request escalated and a home exercise sheet given today |
| Referral | Rheumatology consultation | When the diagnosis is uncertain or before an injection | Completed today | Seen today; thumb-base glucocorticoid injection given |
| Imaging | Hand radiographs | At diagnosis if uncertain; not for routine follow-up | Not indicated | Baseline films last month; no repeat imaging |
| Self-management | Exercise, joint protection, and splint use | Each clinical encounter | Completed today | Splint for carving and at night; home exercises begun today |
| Laboratory | Serum urate | Every 6 months at target | Up to date | 5.4 mg/dL last month |
| Self-management | Fluid intake for stone prevention | Each clinical encounter | Completed today | About 2 L of water a day |
Goal progress:
Guideline basis: 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); 2020 American College of Rheumatology Guideline for the Management of Gout (2020); Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis monograph (2026)
Follow-up: Telephone check one week after the injection. Hand review with pain and function scores four to six weeks after the injection, then at about three months. Next scheduled visit 2026-07-13: hand osteoarthritis review three months after a thumb-base injection. [S]